0.9095
Schlusskurs vom Vortag:
$1.05
Offen:
$0.9
24-Stunden-Volumen:
221.69K
Relative Volume:
3.59
Marktkapitalisierung:
$2.44M
Einnahmen:
$8.27M
Nettoeinkommen (Verlust:
$-17.52M
KGV:
-0.0145
EPS:
-62.6089
Netto-Cashflow:
$-10.90M
1W Leistung:
-2.83%
1M Leistung:
-19.48%
6M Leistung:
-60.58%
1J Leistung:
+2.38%
Nuwellis Inc Stock (NUWE) Company Profile
Firmenname
Nuwellis Inc
Sektor
Branche
Telefon
952-345-4200
Adresse
12988 VALLEY VIEW ROAD, EDEN PRAIRIE
Compare NUWE vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
NUWE
Nuwellis Inc
|
0.9095 | 2.81M | 8.27M | -17.52M | -10.90M | -62.61 |
|
ABT
Abbott Laboratories
|
86.70 | 152.25B | 45.13B | 6.28B | 7.38B | 3.5895 |
|
SYK
Stryker Corp
|
312.36 | 121.33B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
77.84 | 100.91B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
57.83 | 85.88B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
87.78 | 49.39B | 6.30B | 1.07B | 1.09B | 1.8406 |
Nuwellis Inc Stock (NUWE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-29 | Eingeleitet | ROTH MKM | Buy |
Nuwellis Inc Aktie (NUWE) Neueste Nachrichten
Nuwellis Q1 2026 Earnings: Significant EPS Miss Despite Stock GainCommunity Hot Stocks - Newser
Nuwellis Inc. (NUWE) Pushes Past Key Support, Tests Resistance at $1.10Momentum ETF - Newser
NUWE Q1 2026 Earnings: EPS Misses Estimates Sharply, Stock Rises 5.37%Earnings Whisper Number - Newser
Nuwellis Offering Up to 4.85M Shrs, 4.85M Series C Warrants and 4.85M Series D Warrants - Moomoo
Nuwellis (NASDAQ: NUWE) files S-1 for warrant-heavy equity raise - Stock Titan
NUWE Technical Analysis | Trend, Signals & Chart Patterns | NUWELLIS INC (NASDAQ:NUWE) - ChartMill
Nuwellis Q3 Earnings Preview - MSN
Nuwellis (NUWE) Stock Analysis: Climbs +1.19%, Eyes on $1.04 2026-05-20Leveraged ETF Flow - Newser
Nuwellis Q1 earnings preview - MSN
Nuwellis (NASDAQ: NUWE) Q1 2026: 26% sales growth but going-concern risk - Stock Titan
Armistice Capital (NUWE) reports 1.06M shares, 7.11% ownership - Stock Titan
Q1 2026 Nuwellis Inc Earnings Call Transcript - GuruFocus
Nuwellis (NUWE) Advances Pediatric Indication for Aquadex SmartF - GuruFocus
Nuwellis receives FDA feedback on pediatric label expansion By Investing.com - Investing.com South Africa
Nuwellis receives FDA feedback on pediatric label expansion - Investing.com
Nuwellis Announces Successful Completion Of FDA Pre-Submission 510(k) Meeting To Expand Aquadex Label - TradingView
Nuwellis Announces Successful Completion of FDA Pre-Submission 510(k) Meeting to Expand Aquadex Label - The Manila Times
Maxim Group Maintains Nuwellis(NUWE.US) With Hold Rating - Moomoo
Nuwellis moves to let its fluid-removal system treat 5 kg kids - Stock Titan
Nuwellis (NUWE) Gains +5.63% — Support Holds at $1.04 2026-05-14Capital Preservation - Newser
Nuwellis Earnings Call Balances Growth With Cash Strain - The Globe and Mail
Nuwellis Q1 2026 Earnings Call Transcript - Sahm
Nuwellis Inc (NUWE) Q1 2026 Earnings Call Highlights: Strong Rev - GuruFocus
Earnings call transcript: Nuwellis Q1 2026 shows strong revenue growth - Investing.com India
Nuwellis, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Nuwellis (Nasdaq: NUWE) grows Q1 2026 sales 26% but posts $4.3M loss - Stock Titan
Nuwellis Q1 2026 Loss Deepens: -$2.09/Share vs -$1.00 Expected - AlphaStreet
Nuwellis Releases Q1 2026 Financial Results - AlphaStreet
TradingKey - TradingKey
Nuwellis, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Nuwellis Q1 2026 Deep Dive: EPS Misses by 109.0%, Revenue Up 26% - AlphaStreet
Nuwellis Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Earnings call transcript: Nuwellis Q1 2026 shows strong revenue growth By Investing.com - Investing.com Nigeria
MSN Money - MSN
Nuwellis (NUWE) Q1 2026 Earnings Transcript - AOL.com
Nuwellis Shifts to Strategic Execution Following First Quarter Results - HarianBasis.co
NUWE: Revenue up 26% year-over-year, with pediatrics driving growth and gross margin at 70.1% - TradingView
NUWE: Revenue up 26% in Q1 2026, with strong pediatric growth and new kidney monitoring acquisition - TradingView
Transcript : Nuwellis, Inc., Q1 2026 Earnings Call, May 12, 2026 - marketscreener.com
Nuwellis, Inc. Reports First Quarter 2026 Financial Results and Strategic Progress - Quiver Quantitative
Nuwellis, Inc. Announces First Quarter 2026 Financial Results - The Manila Times
Nuwellis grows Q1 sales 26% and adds kidney-monitoring tech - Stock Titan
The opportunity most miss about Nuwellis (NUWE) (Technical Weakness) 2026-05-11AI Powered Stock Picks - newser.com
Finanzdaten der Nuwellis Inc-Aktie (NUWE)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):